These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38730328)

  • 1. Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients.
    Wu L; Wang J; Song D; You Y; Wang Z
    BMC Infect Dis; 2024 May; 24(1):482. PubMed ID: 38730328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Missing zinc finger domains: hemophagocytic lymphohistiocytosis in a GATA2 deficiency patient triggered by non-tuberculous mycobacteriosis.
    Huang X; Wu B; Wu D; Huang X; Shen M
    Front Immunol; 2023; 14():1191757. PubMed ID: 37680631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
    Cohen JI; Dropulic L; Hsu AP; Zerbe CS; Krogmann T; Dowdell K; Hornung RL; Lovell J; Hardy N; Hickstein D; Cowen EW; Calvo KR; Pittaluga S; Holland SM
    Clin Infect Dis; 2016 Jul; 63(1):41-7. PubMed ID: 27169477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA2 mutation with recurrent haemophagocytic lymphohistiocytosis and panniculitis: a case report.
    Sun L; Xu N; Shen M; Wang R; Sun Y; Zhuang J; Zhao Y; Zeng X; Zhang X
    Rheumatology (Oxford); 2021 Jul; 60(7):e229-e231. PubMed ID: 33410496
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel
    Mika T; Vangala D; Eckhardt M; La Rosée P; Lange C; Lehmberg K; Wohlschläger C; Biskup S; Fuchs I; Mann J; Ehl S; Warnatz K; Schroers R
    Front Immunol; 2021; 12():682934. PubMed ID: 34040617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report.
    Mendes-de-Almeida DP; Andrade FG; Borges G; Dos Santos-Bueno FV; Vieira IF; da Rocha LKMDS; Mendes-da-Cruz DA; Zancopé-Oliveira RM; Calado RT; Pombo-de-Oliveira MS
    BMC Med Genet; 2019 Apr; 20(1):64. PubMed ID: 31035956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negative T-Lymphocytes.
    Prader S; Felber M; Volkmer B; Trück J; Schwieger-Briel A; Theiler M; Weibel L; Hambleton S; Seipel K; Vavassori S; Pachlopnik Schmid J
    Front Immunol; 2018; 9():2766. PubMed ID: 30564229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
    El-Mallawany NK; Curry CV; Allen CE
    Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
    Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
    BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA2 mutation underlies hemophagocytic lymphohistiocytosis in an adult with primary cytomegalovirus infection.
    Suzuki T; Takaya S; Kunimatsu J; Kutsuna S; Hayakawa K; Shibata H; Yasumi T; Ohmagari N
    J Infect Chemother; 2020 Feb; 26(2):252-256. PubMed ID: 31350183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
    Song Y; Wang Y; Wang Z
    Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis complicated by neurological involvement in a patient with dermatomyositis: A case report and literature review.
    Xu T; Xiong L; Tang L
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):293-297. PubMed ID: 35861298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell immunoglobulin-like receptor gene polymorphisms predispose susceptibility to Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in Chinese children.
    Qiang Q; Zhengde X; Chunyan L; Zhizhuo H; Junmei X; Junhong A; Zheng C; Henter JI; Kunling S
    Microbiol Immunol; 2012 Jun; 56(6):378-84. PubMed ID: 22376216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.
    Haraguchi M; Harada N; Watanabe J; Yoshikawa H; Shirai Y; Komura M; Koyama M; Ito J; Tsukune Y; Horimoto Y; Hayashi T; Nagaoka T; Uekusa T; Takahashi K
    BMC Infect Dis; 2021 May; 21(1):502. PubMed ID: 34051752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
    Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
    Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Yin Q; Wang J; Wang Z
    Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.